Boston Scientific Announces Results For Second Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Boston Scientific (BSX) PT Raised to $53 at Cowen
July 27, 2021 3:54 PM EDTCowen analyst Joshua Jennings raised the price target on Boston Scientific (NYSE: BSX) to $53.00 (from $47.00) while maintaining an Outperform rating.
The analyst commented, "BSX posted 2Q revenue and EPS of $3.08B and $0.40, beating Street estimates of $2.94B and $0.37. Organic sales growth was 9% compared to... More
Boston Scientific (BSX) Tops Q2 EPS by 3c
July 27, 2021 6:34 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.40, $0.03 better than the analyst estimate of $0.37. Revenue for the quarter came in at $3.08 billion versus the consensus estimate of $2.94 billion.
GUIDANCE:
Boston Scientific sees FY2021 EPS of $1.58-$1.62, versus the consensus of... More
